{"ok":true,"article":{"slug":"pariglasgene-brecaparvovec-opnr-approved-for-glycogen-storage-disease-1a-406fd269","title":"Pariglasgene Brecaparvovec-opnr Approved for Glycogen Storage Disease 1a","url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQcWtGek9aOEg1U1hWWU5sTFZDN0g1bzVjYy1jZlVVbEVaemtXcHZXTEtyQjlOeFc0bTZmd1hueDdHZk5DNFphVVJlU0cxSVp6MF9hU0E1ZXo3MG40eWJKMXJxN3pqYUdoa0FoamdxU0w4c0dnZV9CU0R6M2NMMzB0TW4ta1lYTERCT0EzeE1TdnNqNWxRR25udjJLT2RkZw?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/pariglasgene-brecaparvovec-opnr-approved-for-glycogen-storage-disease-1a-406fd269","sourceName":"CGTLive®","summary":"Related coverage: Pariglasgene Brecaparvovec-opnr Approved for Glycogen Storage Disease 1a CGTLive®","category":"Health","image":null,"lang":"en","publishedAt":"2026-08-20T13:24:31+00:00","createdAt":"2026-08-20T13:30:13.542449+00:00"}}